Xia Ou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Xia Ou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guoyang Liao
The Fifth Department of Biological products Institute of Medical Biology Chinese Academy of Medical Science and Peking Union Medical College Kunming Yunnan Province China
1 shared publication Jianming Xia
The Department of Cardiovascular Medicine, FuWai Yunan Cardiovascular Hospital, Kunming, China
1 shared publication- Jihong Zhang
Laboratory of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, PR China
1 shared publication Weidong Li
The Department of Production Administration Institute of Medical Biology Chinese Academy of Medical Science and Peking Union Medical College Kunming Yunnan Province China
1 shared publicationWeijie Li
Department of Hospital Infection Management, Kunming Children Hospital, Kunming, China
1 shared publicationXingliang Geng
The Fifth Department of Biological products Institute of Medical Biology Chinese Academy of Medical Science and Peking Union Medical College Kunming Yunnan Province China
1 shared publication
Latest Publications
- 25 December 2022
- Published by Taylor & Francis in Journal of Asthma
- Vol. 60 (7) , 1394-1401
Novel role for integrin β4 in asthmatic children infected with Mycoplasma pneumoniae
The regulatory role of integrin β4 (ITGB4) in asthmatic children infected with Mycoplasma pneumoniae (MP) was analyzed, and its potential molecular mechanisms and function were studied. We collected epidemiological data from 70,455 asthmatic children. The immunofluorescence assay was used to test 9 index IgMs against respiratory tract pathogens for 736 serum samples. Then, 98 children with severe asthma were treated via fiberoptic bronchoscope examination. During the surgery, the patients’ lavage fluid was collected. Additionally, differences in transforming growth factor-beta (TGF-β) expression between the MP-infected and noninfected groups were examined. Experiments were performed using white blood cell counting methods and flow cytometry for 98 asthmatic children. We tested 736 specimens, and the percentages of MP, RSV, and ADV infections were 50.27%, 11.68%, and 10.05%, respectively. The percentage of eosinophils was increased significantly in the AS-I-MP group, and their TGF-β expression levels were increased, which was related to tissue fibrosis. Furthermore, MP infection exacerbated the decreasing trend of ITGB4 expression in patients’ blood compared with the noninfected group. In summary, there might be a chain reaction from MP infection to an increase in ITGB4, a decrease in TGF-β, a large accumulation of eosinophils and the development of asthma in children.
- 25 December 2022
- Published by Taylor & Francis in Journal of Asthma
- Vol. 60 (7) , 1394-1401
Novel role for integrin β4 in asthmatic children infected with Mycoplasma pneumoniae
The regulatory role of integrin β4 (ITGB4) in asthmatic children infected with Mycoplasma pneumoniae (MP) was analyzed, and its potential molecular mechanisms and function were studied. We collected epidemiological data from 70,455 asthmatic children. The immunofluorescence assay was used to test 9 index IgMs against respiratory tract pathogens for 736 serum samples. Then, 98 children with severe asthma were treated via fiberoptic bronchoscope examination. During the surgery, the patients’ lavage fluid was collected. Additionally, differences in transforming growth factor-beta (TGF-β) expression between the MP-infected and noninfected groups were examined. Experiments were performed using white blood cell counting methods and flow cytometry for 98 asthmatic children. We tested 736 specimens, and the percentages of MP, RSV, and ADV infections were 50.27%, 11.68%, and 10.05%, respectively. The percentage of eosinophils was increased significantly in the AS-I-MP group, and their TGF-β expression levels were increased, which was related to tissue fibrosis. Furthermore, MP infection exacerbated the decreasing trend of ITGB4 expression in patients’ blood compared with the noninfected group. In summary, there might be a chain reaction from MP infection to an increase in ITGB4, a decrease in TGF-β, a large accumulation of eosinophils and the development of asthma in children.
- Open Access
- 9 September 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (19) , 11198-11210
Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature
We generated plasmid pools for the rapid preparation of candidate vaccine strains, which could grow in the Vero cells at low temperature. Firstly, we cloned in the pHW2000 plasmid each of the eight gene segments (PB2, PB1, PA, hemagglutinin [HA], neuraminidase [NA], NS, NP, M) of two master donor strains (MDS), respectively, A/Yunnan/1/2005Vca(H3N2) and B/Yunnan/2/2005Vca(By), which had Vca phenotype (cold‐adapted phenotype in Vero cells). Secondly, the similar operation was implemented with each of the HA, NA and NP segments of circulating strains with epidemic potential (parental strains). The virus rescue techniques were employed in this study, according to the homology rate of HA segments between MDS and parental strains. Then, we harvested amount of new Vca virus strains. By transmission electron microscope, it could observe new viruses' diameter and length were from 100 to 120 nm. Importantly, these reassortant viruses could get high‐yield production in Vero cells at 25℃ from the beginning to the fourth generation, which was significantly differ from their original parental viruses. Additional, these production 16 new Vca strains could maintain enough antibody binding capacity and attenuation phenotype, which consisted with their MDS. So these plasmid pools constructed by mount of different influenza A and B virus gene fragments could present desired working performance and provide convenience and realization for more Vca reassortant virus as candidate vaccine strain if needing.
- 9 September 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (19) , 11198-11210
Open AccessConstruction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature
We generated plasmid pools for the rapid preparation of candidate vaccine strains, which could grow in the Vero cells at low temperature. Firstly, we cloned in the pHW2000 plasmid each of the eight gene segments (PB2, PB1, PA, hemagglutinin [HA], neuraminidase [NA], NS, NP, M) of two master donor strains (MDS), respectively, A/Yunnan/1/2005Vca(H3N2) and B/Yunnan/2/2005Vca(By), which had Vca phenotype (cold‐adapted phenotype in Vero cells). Secondly, the similar operation was implemented with each of the HA, NA and NP segments of circulating strains with epidemic potential (parental strains). The virus rescue techniques were employed in this study, according to the homology rate of HA segments between MDS and parental strains. Then, we harvested amount of new Vca virus strains. By transmission electron microscope, it could observe new viruses' diameter and length were from 100 to 120 nm. Importantly, these reassortant viruses could get high‐yield production in Vero cells at 25℃ from the beginning to the fourth generation, which was significantly differ from their original parental viruses. Additional, these production 16 new Vca strains could maintain enough antibody binding capacity and attenuation phenotype, which consisted with their MDS. So these plasmid pools constructed by mount of different influenza A and B virus gene fragments could present desired working performance and provide convenience and realization for more Vca reassortant virus as candidate vaccine strain if needing.